{"transactions":[{"id":740765,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-12T22:30:54.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":14965,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of deferred stock units that vest in full on the first anniversary of the grant date, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 42,343 previously reported deferred stock units and an aggregate of 2,103 shares acquired under Orthofix's Stock Purchase Plan (\"Orthofix's SPP\") on 10/31/2025 and 4/30/2026. Orthofix's SPP is a \"Stock Purchase Plan\" as defined in Rule 16b-3(b)(5), and share acquisitions under the plan are exempt from Section 16(b)."}],"balance_after":76305,"source":{"system":"sec-edgar","filing":"0001193125-26-269871","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000119312526269871/ownership.xml","form_type":"4"}},{"id":770116,"issuer":{"id":6440,"kind":"organization","name":"Quantum-Si Inc","symbol":"QSI"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2026-05-20T20:05:24.000Z","date":"2026-05-18","kind":"grant","planned":false,"acquired":true,"shares":251185,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to continued service through the applicable vesting date."}],"balance_after":251185,"derivative":{"exercise_price":0.8539,"expiration_date":"2036-05-18","underlying":"Class A Common Stock","underlying_shares":251185},"source":{"system":"sec-edgar","filing":"0001140361-26-022241","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816431/000114036126022241/form4.xml","form_type":"4"}},{"id":777871,"issuer":{"id":4845,"kind":"organization","name":"Gentherm Inc","symbol":"THRM"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T21:38:28.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":4292,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares represent Restricted Common Stock issued under the 2023 Equity Incentive Plan that has been granted to the Reporting Person as compensation for serving on the Gentherm Board of Directors."}],"balance_after":25937,"source":{"system":"sec-edgar","filing":"0001193125-26-227290","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/903129/000119312526227290/ownership.xml","form_type":"4"}},{"id":853652,"issuer":{"id":6440,"kind":"organization","name":"Quantum-Si Inc","symbol":"QSI"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2026-03-09T10:01:59.000Z","date":"2026-03-05","kind":"purchase","planned":false,"acquired":true,"shares":500000,"price":0.9196,"value":459800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average purchase price per share. The shares were purchased at prices ranging from $0.8906 to $0.9735 per share. Full information regarding the number of shares purchased at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."}],"balance_after":855000,"source":{"system":"sec-edgar","filing":"0001140361-26-008322","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816431/000114036126008322/form4.xml","form_type":"4"}},{"id":1104344,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-23T20:17:19.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":18841,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of deferred stock units that vest in full on the first anniversary of the grant date, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 23,502 previously reported deferred stock units and an aggregate of 1,894 shares acquired under Orthofix's Stock Purchase Plan on 10/31/2024 and 4/30/2025.."}],"balance_after":59237,"source":{"system":"sec-edgar","filing":"0000950170-25-088993","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000095017025088993/ownership.xml","form_type":"4"}},{"id":1139105,"issuer":{"id":6440,"kind":"organization","name":"Quantum-Si Inc","symbol":"QSI"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-05-21T20:01:35.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":126095,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to continued service through the applicable vesting date."}],"balance_after":126095,"derivative":{"exercise_price":1.41,"expiration_date":"2035-05-19","underlying":"Class A Common Stock","underlying_shares":126095},"source":{"system":"sec-edgar","filing":"0001140361-25-020047","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816431/000114036125020047/form4.xml","form_type":"4"}},{"id":1154397,"issuer":{"id":4845,"kind":"organization","name":"Gentherm Inc","symbol":"THRM"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-09T20:50:26.000Z","date":"2025-05-08","kind":"grant","planned":false,"acquired":true,"shares":5075,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares represent Restricted Common Stock issued under the 2023 Equity Incentive Plan that has been granted to the Reporting Person as compensation for serving on the Gentherm Board of Directors."}],"balance_after":21645,"source":{"system":"sec-edgar","filing":"0000950170-25-068169","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/903129/000095017025068169/ownership.xml","form_type":"4"}},{"id":1434897,"issuer":{"id":6440,"kind":"organization","name":"Quantum-Si Inc","symbol":"QSI"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2024-08-13T10:01:24.000Z","date":"2024-08-12","kind":"purchase","planned":false,"acquired":true,"shares":31100,"price":0.8853,"value":27532.83,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average purchase price per share. The shares were purchased at prices ranging from $0.84 to $0.90 per share. Full information regarding the number of shares purchased at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."}],"balance_after":355000,"source":{"system":"sec-edgar","filing":"0001140361-24-036919","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816431/000114036124036919/form4.xml","form_type":"4"}},{"id":1434896,"issuer":{"id":6440,"kind":"organization","name":"Quantum-Si Inc","symbol":"QSI"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2024-08-13T10:01:24.000Z","date":"2024-08-09","kind":"purchase","planned":false,"acquired":true,"shares":138900,"price":0.8706,"value":120926.34,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average purchase price per share. The shares were purchased at prices ranging from $0.85 to $0.89 per share. Full information regarding the number of shares purchased at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."}],"balance_after":323900,"source":{"system":"sec-edgar","filing":"0001140361-24-036919","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816431/000114036124036919/form4.xml","form_type":"4"}},{"id":1473933,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-20T11:07:28.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":15152,"price":12.87,"value":195006.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of deferred stock units that vest in full on the first anniversary of the grant date, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 23,502 deferred stock units."}],"balance_after":38502,"source":{"system":"sec-edgar","filing":"0000950170-24-075305","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000095017024075305/ownership.xml","form_type":"4"}},{"id":1487023,"issuer":{"id":6440,"kind":"organization","name":"Quantum-Si Inc","symbol":"QSI"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true}}],"security":"Stock Option (Right to buy)","published_at":"2024-06-07T20:41:19.000Z","date":"2024-06-07","kind":"grant","planned":false,"acquired":true,"shares":113281,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to Mr. Kummeth's continued service through the applicable vesting date."}],"balance_after":113281,"derivative":{"exercise_price":1.86,"expiration_date":"2034-06-07","underlying":"Class A Common Stock","underlying_shares":113281},"source":{"system":"sec-edgar","filing":"0001140361-24-029298","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816431/000114036124029298/form4.xml","form_type":"4"}},{"id":1497982,"issuer":{"id":6440,"kind":"organization","name":"Quantum-Si Inc","symbol":"QSI"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true}}],"security":"Stock Option (Right to buy)","published_at":"2024-05-30T20:47:42.000Z","date":"2024-05-28","kind":"grant","planned":false,"acquired":true,"shares":527777,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in three equal annual installments beginning May 28, 2025, subject to Mr. Kummeth's continued service through the applicable vesting date."}],"balance_after":527777,"derivative":{"exercise_price":1.58,"expiration_date":"2034-05-28","underlying":"Class A Common Stock","underlying_shares":527777},"source":{"system":"sec-edgar","filing":"0001140361-24-028148","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816431/000114036124028148/form4.xml","form_type":"4"}},{"id":1509651,"issuer":{"id":4845,"kind":"organization","name":"Gentherm Inc","symbol":"THRM"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-20T20:59:14.000Z","date":"2024-05-16","kind":"grant","planned":false,"acquired":true,"shares":2662,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares represent Restricted Common Stock issued under the 2023 Equity Incentive Plan that has been granted to the Reporting Person as compensation for serving on the Gentherm Board of Directors."}],"balance_after":16570,"source":{"system":"sec-edgar","filing":"0000950170-24-062513","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/903129/000095017024062513/ownership.xml","form_type":"4"}},{"id":1582598,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-12T20:29:09.000Z","date":"2024-01-31","kind":"grant","planned":false,"acquired":true,"shares":8350,"price":13.89,"value":115981.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of deferred stock units that vest in full on the earlier of (i) June 30, 2024 or (ii) the date on which the issuer holds its 2024 annual meeting of stockholders, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer."}],"balance_after":23350,"source":{"system":"sec-edgar","filing":"0000950170-24-029983","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000095017024029983/ownership.xml","form_type":"4"}},{"id":1703747,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-12-21T00:07:28.000Z","date":"2023-12-18","kind":"grant","planned":false,"acquired":true,"shares":47652,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, December 18, 2023."}],"balance_after":47652,"derivative":{"exercise_price":13.06,"expiration_date":"2033-12-18","underlying":"Common Stock","underlying_shares":47652},"source":{"system":"sec-edgar","filing":"0001209191-23-059391","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919123059391/doc4.xml","form_type":"4"}},{"id":1804664,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2023-08-17T20:14:54.000Z","date":"2023-08-15","kind":"grant","planned":false,"acquired":true,"shares":59095,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"19,698 shares vest on each of 8/15/2024 and 8/15/2026, and 19,699 shares vest on 8/15/2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"19,698 shares vest on each of 8/15/2024 and 8/15/2026, and 19,699 shares vest on 8/15/2025."}],"balance_after":59095,"derivative":{"underlying":"Common Stock","underlying_shares":59095},"source":{"system":"sec-edgar","filing":"0001062993-23-016707","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299323016707/form4.xml","form_type":"4"}},{"id":1804663,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-08-17T20:14:54.000Z","date":"2023-08-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":8675,"price":84.61,"value":733991.75,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 7,128 shares of restricted stock for which the risk of forfeiture will lapse on August 6, 2024."}],"balance_after":1278269,"source":{"system":"sec-edgar","filing":"0001062993-23-016707","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299323016707/form4.xml","form_type":"4"}},{"id":1804662,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-08-17T20:14:54.000Z","date":"2023-08-15","kind":"exercise","planned":false,"acquired":true,"shares":17632,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 7,128 shares of restricted stock for which the risk of forfeiture will lapse on August 6, 2024."}],"balance_after":1286944,"source":{"system":"sec-edgar","filing":"0001062993-23-016707","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299323016707/form4.xml","form_type":"4"}},{"id":1810350,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-08-11T20:13:19.000Z","date":"2023-08-09","kind":"gift","planned":false,"acquired":false,"shares":9008,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Includes 7,128 shares of restricted stock for which the risk of forfeiture will lapse on August 6, 2024."}],"balance_after":1269312,"source":{"system":"sec-edgar","filing":"0001062993-23-016265","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299323016265/form4.xml","form_type":"4"}},{"id":1813418,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2023-08-08T21:31:05.000Z","date":"2023-08-05","kind":"exercise","planned":false,"acquired":false,"shares":51516,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On 8/5/2023, the Board of Directors certified vesting of 51,516 performance RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On 8/5/2023, the Board of Directors certified vesting of 51,516 performance RSUs."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":51516},"source":{"system":"sec-edgar","filing":"0001062993-23-016040","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299323016040/form4.xml","form_type":"4"}},{"id":1813417,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-08-08T21:31:05.000Z","date":"2023-08-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":31962,"price":82.17,"value":2626317.54,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Includes 7,128 shares of restricted stock for which the risk of forfeiture will lapse on August 6, 2024."}],"balance_after":1278320,"source":{"system":"sec-edgar","filing":"0001062993-23-016040","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299323016040/form4.xml","form_type":"4"}},{"id":1813416,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-08-08T21:31:05.000Z","date":"2023-08-05","kind":"exercise","planned":false,"acquired":true,"shares":51516,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Includes 7,128 shares of restricted stock for which the risk of forfeiture will lapse on August 6, 2024."}],"balance_after":1310282,"source":{"system":"sec-edgar","filing":"0001062993-23-016040","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299323016040/form4.xml","form_type":"4"}},{"id":1823801,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-07-25T21:27:42.000Z","date":"2023-07-21","kind":"sale","planned":true,"acquired":false,"shares":80000,"price":88.3628,"value":7069024.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.00 to $88.95 inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Includes (i) 11,448 shares of restricted stock for which the risk of forfeiture will lapse on August 5, 2023; and (ii) 14,248 shares of restricted stock for which the risk of forfeiture will lapse as to 7,128 shares on each of August 6, 2023 and August 6, 2024."}],"balance_after":1258766,"source":{"system":"sec-edgar","filing":"0001062993-23-015315","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299323015315/form4.xml","form_type":"4"}},{"id":1838287,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2023-07-05T22:38:34.000Z","date":"2023-06-30","kind":"exercise","planned":false,"acquired":false,"shares":616676,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":26.65,"expiration_date":"2023-08-18","underlying":"Common Stock","underlying_shares":616676},"source":{"system":"sec-edgar","filing":"0001062993-23-014515","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299323014515/form4.xml","form_type":"4"}},{"id":1838286,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-07-05T22:38:34.000Z","date":"2023-06-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":390727,"price":81.63,"value":31895045.01,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Includes (i) 11,448 shares of restricted stock for which the risk of forfeiture will lapse on August 5, 2023; and (ii) 14,248 shares of restricted stock for which the risk of forfeiture will lapse as to 7,128 shares on each of August 6, 2023 and August 6, 2024."}],"balance_after":1338766,"source":{"system":"sec-edgar","filing":"0001062993-23-014515","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299323014515/form4.xml","form_type":"4"}},{"id":1838285,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-07-05T22:38:34.000Z","date":"2023-06-30","kind":"exercise","planned":false,"acquired":true,"shares":616676,"price":26.65,"value":16434415.4,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Includes (i) 11,448 shares of restricted stock for which the risk of forfeiture will lapse on August 5, 2023; and (ii) 14,248 shares of restricted stock for which the risk of forfeiture will lapse as to 7,128 shares on each of August 6, 2023 and August 6, 2024."}],"balance_after":1729493,"source":{"system":"sec-edgar","filing":"0001062993-23-014515","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299323014515/form4.xml","form_type":"4"}},{"id":1861386,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-06-09T20:07:56.000Z","date":"2023-06-07","kind":"sale","planned":false,"acquired":false,"shares":322,"price":83,"value":26726.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Includes (i) 11,448 shares of restricted stock for which the risk of forfeiture will lapse on August 5, 2023; and (ii) 14,248 shares of restricted stock for which the risk of forfeiture will lapse as to 7,128 shares on each of August 6, 2023 and August 6, 2024."}],"balance_after":1112817,"source":{"system":"sec-edgar","filing":"0001062993-23-013263","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299323013263/form4.xml","form_type":"4"}},{"id":1883354,"issuer":{"id":4845,"kind":"organization","name":"Gentherm Inc","symbol":"THRM"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-22T20:24:41.000Z","date":"2023-05-18","kind":"grant","planned":false,"acquired":true,"shares":2147,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares represent Restricted Common Stock issued under the 2023 Equity Incentive Plan that has been granted to the Reporting Person as compensation for serving on the Gentherm Board of Directors."}],"balance_after":13908,"source":{"system":"sec-edgar","filing":"0001209191-23-031459","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/903129/000120919123031459/doc4.xml","form_type":"4"}},{"id":2061134,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2023-01-06T21:37:56.000Z","date":"2023-01-04","kind":"exercise","acquired":false,"shares":407364,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully exercisable."}],"balance_after":616676,"derivative":{"exercise_price":26.65,"expiration_date":"2023-08-18","underlying":"Common Stock","underlying_shares":407364},"source":{"system":"sec-edgar","filing":"0001062993-23-000628","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299323000628/form4.xml","form_type":"4"}},{"id":2061133,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-06T21:37:56.000Z","date":"2023-01-04","kind":"tax_withholding","acquired":false,"shares":255837,"price":84.39,"value":21590084.43,"ownership":{"direct":true},"balance_after":1113139,"source":{"system":"sec-edgar","filing":"0001062993-23-000628","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299323000628/form4.xml","form_type":"4"}},{"id":2061132,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-06T21:37:56.000Z","date":"2023-01-04","kind":"exercise","acquired":true,"shares":407364,"price":26.65,"value":10856250.6,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes (i) 11,448 shares of restricted stock for which the risk of forfeiture will lapse on August 5, 2023; and (ii) 14,248 shares of restricted stock for which the risk of forfeiture will lapse as to 7,128 shares on each of August 6, 2023 and August 6, 2024."}],"balance_after":1368976,"source":{"system":"sec-edgar","filing":"0001062993-23-000628","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299323000628/form4.xml","form_type":"4"}},{"id":2182891,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-08-17T21:23:01.000Z","date":"2022-08-15","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"150,000 options vest in full or in part on 7/1/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator), and 150,000 options vest in full or in part on 7/1/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator)."}],"balance_after":300000,"derivative":{"exercise_price":378.08,"expiration_date":"2029-08-15","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001437749-22-020846","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/842023/000143774922020846/rdgdoc.xml","form_type":"4"}},{"id":2182890,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2022-08-17T21:23:01.000Z","date":"2022-08-15","kind":"grant","acquired":true,"shares":13225,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"4,408 shares vest on each of 8/15/2023 and 8/15/2025, and 4,409 shares vest on 8/15/2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"4,408 shares vest on each of 8/15/2023 and 8/15/2025, and 4,409 shares vest on 8/15/2024."}],"balance_after":13225,"derivative":{"underlying":"Common Stock","underlying_shares":13225},"source":{"system":"sec-edgar","filing":"0001437749-22-020846","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/842023/000143774922020846/rdgdoc.xml","form_type":"4"}},{"id":2191442,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2022-08-09T22:58:29.000Z","date":"2022-08-07","kind":"exercise","acquired":false,"shares":16937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On 8/7/2022, the Board of Directors certified vesting of 16,937 performance RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On 8/7/2022, the Board of Directors certified vesting of 16,937 performance RSUs."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":16937},"source":{"system":"sec-edgar","filing":"0001437749-22-019663","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/842023/000143774922019663/rdgdoc.xml","form_type":"4"}},{"id":2191441,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-08-09T22:58:29.000Z","date":"2022-08-07","kind":"tax_withholding","acquired":false,"shares":11557,"price":382.97,"value":4425984.29,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes (i) 2,862 shares of restricted stock for which the risk of forfeiture will lapse on August 5, 2023; and (ii) 3,562 shares of restricted stock for which the risk of forfeiture will lapse as to 1,782 shares on each of August 6, 2023 and August 6, 2024."}],"balance_after":240403,"source":{"system":"sec-edgar","filing":"0001437749-22-019663","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000143774922019663/rdgdoc.xml","form_type":"4"}},{"id":2191440,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-08-09T22:58:29.000Z","date":"2022-08-07","kind":"exercise","acquired":true,"shares":16918,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes (i) 2,862 shares of restricted stock for which the risk of forfeiture will lapse on August 5, 2023; and (ii) 3,562 shares of restricted stock for which the risk of forfeiture will lapse as to 1,782 shares on each of August 6, 2023 and August 6, 2024."}],"balance_after":251960,"source":{"system":"sec-edgar","filing":"0001437749-22-019663","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000143774922019663/rdgdoc.xml","form_type":"4"}},{"id":2199619,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2022-08-01T22:11:06.000Z","date":"2022-07-28","kind":"exercise","acquired":false,"shares":45346,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":108.49,"expiration_date":"2022-08-07","underlying":"Common Stock","underlying_shares":45346},"source":{"system":"sec-edgar","filing":"0001415889-22-008078","document":"form4-08012022_030829.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/842023/000141588922008078/form4-08012022_030829.xml","form_type":"4"}},{"id":2199618,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2022-08-01T22:11:06.000Z","date":"2022-07-28","kind":"tax_withholding","acquired":false,"shares":27707,"price":380.76,"value":10549717.32,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes (i) 3,763 shares of restricted stock for which the risk of forfeiture will lapse on August 7, 2022; (ii) 5,724 shares of restricted stock for which the risk of forfeiture will lapse as to 2,862 shares on each of August 5, 2022 and August 5, 2023; and (iii) 5,344 shares of restricted stock for which the risk of forfeiture will lapse as to 1,782 shares on August 6, 2022 and as to 1,781 shares on each of August 6, 2023 and August 6, 2024."}],"balance_after":235042,"source":{"system":"sec-edgar","filing":"0001415889-22-008078","document":"form4-08012022_030829.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000141588922008078/form4-08012022_030829.xml","form_type":"4"}},{"id":2199617,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2022-08-01T22:11:06.000Z","date":"2022-07-28","kind":"exercise","acquired":true,"shares":45346,"price":108.49,"value":4919587.54,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes (i) 3,763 shares of restricted stock for which the risk of forfeiture will lapse on August 7, 2022; (ii) 5,724 shares of restricted stock for which the risk of forfeiture will lapse as to 2,862 shares on each of August 5, 2022 and August 5, 2023; and (iii) 5,344 shares of restricted stock for which the risk of forfeiture will lapse as to 1,782 shares on August 6, 2022 and as to 1,781 shares on each of August 6, 2023 and August 6, 2024."}],"balance_after":262749,"source":{"system":"sec-edgar","filing":"0001415889-22-008078","document":"form4-08012022_030829.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000141588922008078/form4-08012022_030829.xml","form_type":"4"}},{"id":2210341,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2022-07-08T21:18:52.000Z","date":"2022-07-06","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully exercisable."}],"balance_after":45346,"derivative":{"exercise_price":108.49,"expiration_date":"2022-08-07","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-22-007599","document":"form4-07082022_020741.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/842023/000141588922007599/form4-07082022_020741.xml","form_type":"4"}},{"id":2210340,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2022-07-08T21:18:52.000Z","date":"2022-07-06","kind":"tax_withholding","acquired":false,"shares":30935,"price":362.78,"value":11222599.3,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes (i) 3,763 shares of restricted stock for which the risk of forfeiture will lapse on August 7, 2022; (ii) 5,724 shares of restricted stock for which the risk of forfeiture will lapse as to 2,862 shares on each of August 5, 2022 and August 5, 2023; and (iii) 5,344 shares of restricted stock for which the risk of forfeiture will lapse as to 1,782 shares on August 6, 2022 and as to 1,781 shares on each of August 6, 2023 and August 6, 2024."}],"balance_after":217403,"source":{"system":"sec-edgar","filing":"0001415889-22-007599","document":"form4-07082022_020741.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000141588922007599/form4-07082022_020741.xml","form_type":"4"}},{"id":2210339,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2022-07-08T21:18:52.000Z","date":"2022-07-06","kind":"exercise","acquired":true,"shares":50000,"price":108.49,"value":5424500.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes (i) 3,763 shares of restricted stock for which the risk of forfeiture will lapse on August 7, 2022; (ii) 5,724 shares of restricted stock for which the risk of forfeiture will lapse as to 2,862 shares on each of August 5, 2022 and August 5, 2023; and (iii) 5,344 shares of restricted stock for which the risk of forfeiture will lapse as to 1,782 shares on August 6, 2022 and as to 1,781 shares on each of August 6, 2023 and August 6, 2024."}],"balance_after":248338,"source":{"system":"sec-edgar","filing":"0001415889-22-007599","document":"form4-07082022_020741.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000141588922007599/form4-07082022_020741.xml","form_type":"4"}},{"id":2238321,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2022-06-09T21:05:32.000Z","date":"2022-06-07","kind":"exercise","acquired":false,"shares":5104,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully exercisable."}],"balance_after":95346,"derivative":{"exercise_price":108.49,"expiration_date":"2022-08-07","underlying":"Common Stock","underlying_shares":5104},"source":{"system":"sec-edgar","filing":"0001415889-22-006391","document":"form4-06092022_020617.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/842023/000141588922006391/form4-06092022_020617.xml","form_type":"4"}},{"id":2238320,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2022-06-09T21:05:32.000Z","date":"2022-06-07","kind":"sale","acquired":false,"shares":5104,"price":365,"value":1862960.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes (i) 3,763 shares of restricted stock for which the risk of forfeiture will lapse on August 7, 2022; (ii) 5,724 shares of restricted stock for which the risk of forfeiture will lapse as to 2,862 shares on each of August 5, 2022 and August 5, 2023; and (iii) 5,344 shares of restricted stock for which the risk of forfeiture will lapse as to 1,782 shares on August 6, 2022 and as to 1,781 shares on each of August 6, 2023 and August 6, 2024."}],"balance_after":198338,"source":{"system":"sec-edgar","filing":"0001415889-22-006391","document":"form4-06092022_020617.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000141588922006391/form4-06092022_020617.xml","form_type":"4"}},{"id":2238319,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2022-06-09T21:05:32.000Z","date":"2022-06-07","kind":"exercise","acquired":true,"shares":5104,"price":108.49,"value":553732.96,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes (i) 3,763 shares of restricted stock for which the risk of forfeiture will lapse on August 7, 2022; (ii) 5,724 shares of restricted stock for which the risk of forfeiture will lapse as to 2,862 shares on each of August 5, 2022 and August 5, 2023; and (iii) 5,344 shares of restricted stock for which the risk of forfeiture will lapse as to 1,782 shares on August 6, 2022 and as to 1,781 shares on each of August 6, 2023 and August 6, 2024."}],"balance_after":203442,"source":{"system":"sec-edgar","filing":"0001415889-22-006391","document":"form4-06092022_020617.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000141588922006391/form4-06092022_020617.xml","form_type":"4"}},{"id":2243040,"issuer":{"id":4845,"kind":"organization","name":"Gentherm Inc","symbol":"THRM"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-06T16:05:45.000Z","date":"2022-06-02","kind":"grant","acquired":true,"shares":1700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares represent Restricted Common Stock issued under the 2013 Equity Incentive Plan that has been granted to the Reporting Person as compensation for serving on the Gentherm Board of Directors."}],"balance_after":11761,"source":{"system":"sec-edgar","filing":"0001209191-22-034446","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/903129/000120919122034446/doc4.xml","form_type":"4"}},{"id":2420078,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-02-01T21:35:07.000Z","date":"2022-01-28","kind":"exercise","acquired":false,"shares":799,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully exercisable."}],"balance_after":194771,"derivative":{"exercise_price":125.05,"expiration_date":"2024-08-09","underlying":"Common Stock","underlying_shares":799},"source":{"system":"sec-edgar","filing":"0001437749-22-002103","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/842023/000143774922002103/rdgdoc.xml","form_type":"4"}},{"id":2420077,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-02-01T21:35:07.000Z","date":"2022-01-28","kind":"exercise","acquired":false,"shares":938,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully exercisable."}],"balance_after":256010,"derivative":{"exercise_price":106.59,"expiration_date":"2023-08-18","underlying":"Common Stock","underlying_shares":938},"source":{"system":"sec-edgar","filing":"0001437749-22-002103","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/842023/000143774922002103/rdgdoc.xml","form_type":"4"}},{"id":2420076,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-02-01T21:35:07.000Z","date":"2022-01-28","kind":"exercise","acquired":true,"shares":799,"price":125.05,"value":99914.95,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes (i) 3,763 shares of restricted stock for which the risk of forfeiture will lapse on August 7, 2022; (ii) 5,724 shares of restricted stock for which the risk of forfeiture will lapse as to 2,862 shares on each of August 5, 2022 and August 5, 2023; and (iii) 5,344 shares of restricted stock for which the risk of forfeiture will lapse as to 1,782 shares on August 6, 2022 and as to 1,781 shares on each of August 6, 2023 and August 6, 2024."}],"balance_after":198338,"source":{"system":"sec-edgar","filing":"0001437749-22-002103","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/842023/000143774922002103/rdgdoc.xml","form_type":"4"}},{"id":2420075,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-02-01T21:35:07.000Z","date":"2022-01-28","kind":"exercise","acquired":true,"shares":938,"price":106.59,"value":99981.42,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes (i) 3,763 shares of restricted stock for which the risk of forfeiture will lapse on August 7, 2022; (ii) 5,724 shares of restricted stock for which the risk of forfeiture will lapse as to 2,862 shares on each of August 5, 2022 and August 5, 2023; and (iii) 5,344 shares of restricted stock for which the risk of forfeiture will lapse as to 1,782 shares on August 6, 2022 and as to 1,781 shares on each of August 6, 2023 and August 6, 2024."}],"balance_after":197539,"source":{"system":"sec-edgar","filing":"0001437749-22-002103","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/842023/000143774922002103/rdgdoc.xml","form_type":"4"}},{"id":2577948,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-09-07T21:00:46.000Z","date":"2021-09-02","kind":"exercise","acquired":false,"shares":73492,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully exercisable."}],"balance_after":100450,"derivative":{"exercise_price":108.49,"expiration_date":"2022-08-07","underlying":"Common Stock","underlying_shares":73492},"source":{"system":"sec-edgar","filing":"0000914190-21-000360","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000360/edgar.xml","form_type":"4"}},{"id":2577947,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-09-07T21:00:46.000Z","date":"2021-09-02","kind":"tax_withholding","acquired":false,"shares":42005,"price":510.78,"value":21455313.9,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes (i) 3,763 shares of restricted stock for which the risk of forfeiture will lapse on August 7, 2022; (ii) 5,724 shares of restricted stock for which the risk of forfeiture will lapse as to 2,862 shares on each of August 5, 2022 and August 5, 2023; and (iii) 5,344 shares of restricted stock for which the risk of forfeiture will lapse as to 1,782 shares on August 6, 2022 and as to 1,781 shares on each of August 6, 2023 and August 6, 2024."}],"balance_after":196601,"source":{"system":"sec-edgar","filing":"0000914190-21-000360","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000360/edgar.xml","form_type":"4"}},{"id":2577946,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-09-07T21:00:46.000Z","date":"2021-09-02","kind":"exercise","acquired":true,"shares":73492,"price":108.49,"value":7973147.08,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes (i) 3,763 shares of restricted stock for which the risk of forfeiture will lapse on August 7, 2022; (ii) 5,724 shares of restricted stock for which the risk of forfeiture will lapse as to 2,862 shares on each of August 5, 2022 and August 5, 2023; and (iii) 5,344 shares of restricted stock for which the risk of forfeiture will lapse as to 1,782 shares on August 6, 2022 and as to 1,781 shares on each of August 6, 2023 and August 6, 2024."}],"balance_after":238606,"source":{"system":"sec-edgar","filing":"0000914190-21-000360","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000360/edgar.xml","form_type":"4"}},{"id":2604556,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-08-13T20:03:30.000Z","date":"2021-08-11","kind":"exercise","acquired":false,"shares":921,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully exercisable."}],"balance_after":173942,"derivative":{"exercise_price":108.49,"expiration_date":"2022-08-07","underlying":"Common Stock","underlying_shares":921},"source":{"system":"sec-edgar","filing":"0000914190-21-000260","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000260/edgar.xml","form_type":"4"}},{"id":2604555,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-08-13T20:03:30.000Z","date":"2021-08-11","kind":"exercise","acquired":true,"shares":921,"price":108.49,"value":99919.29,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes (i) 3,763 shares of restricted stock for which the risk of forfeiture will lapse on August 7, 2022; (ii) 5,724 shares of restricted stock for which the risk of forfeiture will lapse as to 2,862 shares on each of August 5, 2022 and August 5, 2023; and (iii) 5,344 shares of restricted stock for which the risk of forfeiture will lapse as to 1,782 shares on August 6, 2022 and as to 1,781 shares on each of August 6, 2023 and August 6, 2024."}],"balance_after":165114,"source":{"system":"sec-edgar","filing":"0000914190-21-000260","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000260/edgar.xml","form_type":"4"}},{"id":2609302,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-08-10T22:22:31.000Z","date":"2021-08-06","kind":"grant","acquired":true,"shares":20876,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"Options to purchase 5,219 shares vest on each of 8/6/2022, 8/6/2023, 8/6/2024 and 8/6/2025."}],"balance_after":20876,"derivative":{"exercise_price":481.82,"expiration_date":"2028-08-06","underlying":"Common Stock","underlying_shares":20876},"source":{"system":"sec-edgar","filing":"0000914190-21-000217","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":25,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000217/edgar.xml","form_type":"4"}},{"id":2609301,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-08-10T22:22:31.000Z","date":"2021-08-06","kind":"grant","acquired":true,"shares":31315,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator)."}],"balance_after":31315,"derivative":{"exercise_price":481.82,"expiration_date":"2028-08-06","underlying":"Common Stock","underlying_shares":31315},"source":{"system":"sec-edgar","filing":"0000914190-21-000217","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000217/edgar.xml","form_type":"4"}},{"id":2609300,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-08-10T22:22:31.000Z","date":"2021-08-06","kind":"grant","acquired":true,"shares":8016,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F12","text":"Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator)."}],"balance_after":8016,"derivative":{"underlying":"Common Stock","underlying_shares":8016},"source":{"system":"sec-edgar","filing":"0000914190-21-000217","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000217/edgar.xml","form_type":"4"}},{"id":2609299,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-08-10T22:22:31.000Z","date":"2021-08-06","kind":"exercise","acquired":false,"shares":16918,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Vested in full on 8/8/2021 upon the certification of achievement of performance goals."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Vested in full on 8/8/2021 upon the certification of achievement of performance goals."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":16918},"source":{"system":"sec-edgar","filing":"0000914190-21-000217","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000217/edgar.xml","form_type":"4"}},{"id":2609298,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-08-10T22:22:31.000Z","date":"2021-08-06","kind":"tax_withholding","acquired":false,"shares":12475,"price":481.82,"value":6010704.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes (i) 3,763 shares of restricted stock for which the risk of forfeiture will lapse on August 7, 2022; (ii) 5,724 shares of restricted stock for which the risk of forfeiture will lapse as to 2,862 shares on each of August 5, 2022 and August 5, 2023; and (iii) 5,344 shares of restricted stock for which the risk of forfeiture will lapse as to 1,782 shares on August 6, 2022 and as to 1,781 shares on each of August 6, 2023 and August 6, 2024."}],"balance_after":164193,"source":{"system":"sec-edgar","filing":"0000914190-21-000217","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000217/edgar.xml","form_type":"4"}},{"id":2609297,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-08-10T22:22:31.000Z","date":"2021-08-06","kind":"exercise","acquired":true,"shares":16918,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes (i) 3,763 shares of restricted stock for which the risk of forfeiture will lapse on August 7, 2022; (ii) 5,724 shares of restricted stock for which the risk of forfeiture will lapse as to 2,862 shares on each of August 5, 2022 and August 5, 2023; and (iii) 5,344 shares of restricted stock for which the risk of forfeiture will lapse as to 1,782 shares on August 6, 2022 and as to 1,781 shares on each of August 6, 2023 and August 6, 2024."}],"balance_after":176668,"source":{"system":"sec-edgar","filing":"0000914190-21-000217","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000217/edgar.xml","form_type":"4"}},{"id":2609296,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-08-10T22:22:31.000Z","date":"2021-08-06","kind":"grant","acquired":true,"shares":5344,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes (i) 3,763 shares of restricted stock for which the risk of forfeiture will lapse on August 7, 2022; (ii) 5,724 shares of restricted stock for which the risk of forfeiture will lapse as to 2,862 shares on each of August 5, 2022 and August 5, 2023; and (iii) 5,344 shares of restricted stock for which the risk of forfeiture will lapse as to 1,782 shares on August 6, 2022 and as to 1,781 shares on each of August 6, 2023 and August 6, 2024."}],"balance_after":159750,"source":{"system":"sec-edgar","filing":"0000914190-21-000217","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000217/edgar.xml","form_type":"4"}},{"id":2662267,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-06-21T20:36:53.000Z","date":"2021-06-18","kind":"sale","acquired":false,"shares":326,"price":450.37,"value":146820.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 18, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $450.37 to $450.625, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes (i) 3,759 shares of restricted stock for which the risk of forfeiture will lapse on August 8, 2021; (ii) 7,527 shares of restricted stock for which the risk of forfeiture will lapse with respect to 3,764 shares on August 7, 2021 and as to 3,763 shares on August 7, 2022; and (iii) 8,586 shares of restricted stock for which the risk of forfeiture will lapse as to 2,862 shares on each of August 5, 2021, August 5, 2022 and August 5, 2023."}],"balance_after":154406,"source":{"system":"sec-edgar","filing":"0000914190-21-000187","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000187/edgar.xml","form_type":"4"}},{"id":2662266,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-06-21T20:36:53.000Z","date":"2021-06-18","kind":"sale","acquired":false,"shares":2583,"price":449.09,"value":1159999.47,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 18, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $449.00 to $449.63, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes (i) 3,759 shares of restricted stock for which the risk of forfeiture will lapse on August 8, 2021; (ii) 7,527 shares of restricted stock for which the risk of forfeiture will lapse with respect to 3,764 shares on August 7, 2021 and as to 3,763 shares on August 7, 2022; and (iii) 8,586 shares of restricted stock for which the risk of forfeiture will lapse as to 2,862 shares on each of August 5, 2021, August 5, 2022 and August 5, 2023."}],"balance_after":154732,"source":{"system":"sec-edgar","filing":"0000914190-21-000187","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000187/edgar.xml","form_type":"4"}},{"id":2662265,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-06-21T20:36:53.000Z","date":"2021-06-17","kind":"sale","acquired":false,"shares":109,"price":452.13,"value":49282.17,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 18, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes (i) 3,759 shares of restricted stock for which the risk of forfeiture will lapse on August 8, 2021; (ii) 7,527 shares of restricted stock for which the risk of forfeiture will lapse with respect to 3,764 shares on August 7, 2021 and as to 3,763 shares on August 7, 2022; and (iii) 8,586 shares of restricted stock for which the risk of forfeiture will lapse as to 2,862 shares on each of August 5, 2021, August 5, 2022 and August 5, 2023."}],"balance_after":157315,"source":{"system":"sec-edgar","filing":"0000914190-21-000187","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000187/edgar.xml","form_type":"4"}},{"id":2662264,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-06-21T20:36:53.000Z","date":"2021-06-17","kind":"sale","acquired":false,"shares":1050,"price":451.54,"value":474117.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 18, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $451.02 to $452.02, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes (i) 3,759 shares of restricted stock for which the risk of forfeiture will lapse on August 8, 2021; (ii) 7,527 shares of restricted stock for which the risk of forfeiture will lapse with respect to 3,764 shares on August 7, 2021 and as to 3,763 shares on August 7, 2022; and (iii) 8,586 shares of restricted stock for which the risk of forfeiture will lapse as to 2,862 shares on each of August 5, 2021, August 5, 2022 and August 5, 2023."}],"balance_after":157424,"source":{"system":"sec-edgar","filing":"0000914190-21-000187","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000187/edgar.xml","form_type":"4"}},{"id":2662263,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-06-21T20:36:53.000Z","date":"2021-06-17","kind":"sale","acquired":false,"shares":1698,"price":450.39,"value":764762.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 18, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $450.075 to $450.95, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes (i) 3,759 shares of restricted stock for which the risk of forfeiture will lapse on August 8, 2021; (ii) 7,527 shares of restricted stock for which the risk of forfeiture will lapse with respect to 3,764 shares on August 7, 2021 and as to 3,763 shares on August 7, 2022; and (iii) 8,586 shares of restricted stock for which the risk of forfeiture will lapse as to 2,862 shares on each of August 5, 2021, August 5, 2022 and August 5, 2023."}],"balance_after":158474,"source":{"system":"sec-edgar","filing":"0000914190-21-000187","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000187/edgar.xml","form_type":"4"}},{"id":2662262,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-06-21T20:36:53.000Z","date":"2021-06-17","kind":"sale","acquired":false,"shares":6732,"price":449.35,"value":3025024.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 18, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $449.00 to $449.94, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes (i) 3,759 shares of restricted stock for which the risk of forfeiture will lapse on August 8, 2021; (ii) 7,527 shares of restricted stock for which the risk of forfeiture will lapse with respect to 3,764 shares on August 7, 2021 and as to 3,763 shares on August 7, 2022; and (iii) 8,586 shares of restricted stock for which the risk of forfeiture will lapse as to 2,862 shares on each of August 5, 2021, August 5, 2022 and August 5, 2023."}],"balance_after":160172,"source":{"system":"sec-edgar","filing":"0000914190-21-000187","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000187/edgar.xml","form_type":"4"}},{"id":2667173,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-06-16T23:22:16.000Z","date":"2021-06-14","kind":"sale","acquired":false,"shares":349,"price":450.1,"value":157084.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 18, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes (i) 3,759 shares of restricted stock for which the risk of forfeiture will lapse on August 8, 2021; (ii) 7,527 shares of restricted stock for which the risk of forfeiture will lapse with respect to 3,764 shares on August 7, 2021 and as to 3,763 shares on August 7, 2022; and (iii) 8,586 shares of restricted stock for which the risk of forfeiture will lapse as to 2,862 shares on each of August 5, 2021, August 5, 2022 and August 5, 2023."}],"balance_after":166904,"source":{"system":"sec-edgar","filing":"0000914190-21-000185","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000185/edgar.xml","form_type":"4"}},{"id":2667172,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-06-16T23:22:16.000Z","date":"2021-06-14","kind":"sale","acquired":false,"shares":7132,"price":449.1,"value":3202981.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 18, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $449.00 to $449.97, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes (i) 3,759 shares of restricted stock for which the risk of forfeiture will lapse on August 8, 2021; (ii) 7,527 shares of restricted stock for which the risk of forfeiture will lapse with respect to 3,764 shares on August 7, 2021 and as to 3,763 shares on August 7, 2022; and (iii) 8,586 shares of restricted stock for which the risk of forfeiture will lapse as to 2,862 shares on each of August 5, 2021, August 5, 2022 and August 5, 2023."}],"balance_after":167253,"source":{"system":"sec-edgar","filing":"0000914190-21-000185","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000185/edgar.xml","form_type":"4"}},{"id":2694284,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-05-27T20:25:54.000Z","date":"2021-05-25","kind":"exercise","acquired":false,"shares":36849,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":94.35,"expiration_date":"2021-08-12","underlying":"Common Stock","underlying_shares":36849},"source":{"system":"sec-edgar","filing":"0000914190-21-000165","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000165/edgar.xml","form_type":"4"}},{"id":2694283,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-05-27T20:25:54.000Z","date":"2021-05-25","kind":"tax_withholding","acquired":false,"shares":21305,"price":420.12,"value":8950656.6,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes (i) 3,759 shares of restricted stock for which the risk of forfeiture will lapse on August 8, 2021; (ii) 7,527 shares of restricted stock for which the risk of forfeiture will lapse with respect to 3,764 shares on August 7, 2021 and as to 3,763 shares on August 7, 2022; and (iii) 8,586 shares of restricted stock for which the risk of forfeiture will lapse as to 2,862 shares on each of August 5, 2021, August 5, 2022 and August 5, 2023."}],"balance_after":174385,"source":{"system":"sec-edgar","filing":"0000914190-21-000165","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000165/edgar.xml","form_type":"4"}},{"id":2694282,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-05-27T20:25:54.000Z","date":"2021-05-25","kind":"exercise","acquired":true,"shares":36849,"price":94.35,"value":3476703.15,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes (i) 3,759 shares of restricted stock for which the risk of forfeiture will lapse on August 8, 2021; (ii) 7,527 shares of restricted stock for which the risk of forfeiture will lapse with respect to 3,764 shares on August 7, 2021 and as to 3,763 shares on August 7, 2022; and (iii) 8,586 shares of restricted stock for which the risk of forfeiture will lapse as to 2,862 shares on each of August 5, 2021, August 5, 2022 and August 5, 2023."}],"balance_after":195690,"source":{"system":"sec-edgar","filing":"0000914190-21-000165","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000165/edgar.xml","form_type":"4"}},{"id":2699666,"issuer":{"id":4845,"kind":"organization","name":"Gentherm Inc","symbol":"THRM"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-24T19:48:39.000Z","date":"2021-05-20","kind":"grant","acquired":true,"shares":1422,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares represent Restricted Common Stock issued under the 2013 Equity Incentive Plan that has been granted to the Reporting Person as compensation for serving on the Gentherm Board of Directors."}],"balance_after":10061,"source":{"system":"sec-edgar","filing":"0001209191-21-035287","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/903129/000120919121035287/doc4.xml","form_type":"4"}},{"id":2852235,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-02-18T21:38:55.000Z","date":"2021-02-16","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully exercisable."}],"balance_after":36849,"derivative":{"exercise_price":94.35,"expiration_date":"2021-08-12","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000914190-21-000067","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000067/edgar.xml","form_type":"4"}},{"id":2852234,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-18T21:38:55.000Z","date":"2021-02-16","kind":"tax_withholding","acquired":false,"shares":17428,"price":411,"value":7162908.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes (i) 3,759 shares of restricted stock for which the risk of forfeiture will lapse on August 8, 2021; (ii) 7,527 shares of restricted stock for which the risk of forfeiture will lapse with respect to 3,764 shares on August 7, 2021 and as to 3,763 shares on August 7, 2022; and (iii) 8,586 shares of restricted stock for which the risk of forfeiture will lapse as to 2,862 shares on each of August 5, 2021, August 5, 2022 and August 5, 2023."}],"balance_after":158841,"source":{"system":"sec-edgar","filing":"0000914190-21-000067","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000067/edgar.xml","form_type":"4"}},{"id":2852233,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-18T21:38:55.000Z","date":"2021-02-16","kind":"exercise","acquired":true,"shares":30000,"price":94.35,"value":2830500.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes (i) 3,759 shares of restricted stock for which the risk of forfeiture will lapse on August 8, 2021; (ii) 7,527 shares of restricted stock for which the risk of forfeiture will lapse with respect to 3,764 shares on August 7, 2021 and as to 3,763 shares on August 7, 2022; and (iii) 8,586 shares of restricted stock for which the risk of forfeiture will lapse as to 2,862 shares on each of August 5, 2021, August 5, 2022 and August 5, 2023."}],"balance_after":176269,"source":{"system":"sec-edgar","filing":"0000914190-21-000067","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000067/edgar.xml","form_type":"4"}},{"id":2903435,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-01-20T21:42:59.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":20000,"price":344,"value":6880000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (i) 3,759 shares of restricted stock for which the risk of forfeiture will lapse on August 8, 2021; (ii) 7,527 shares of restricted stock for which the risk of forfeiture will lapse with respect to 3,764 shares on August 7, 2021 and as to 3,763 shares on August 7, 2022; and (iii) 8,586 shares of restricted stock for which the risk of forfeiture will lapse as to 2,862 shares on each of August 5, 2021, August 5, 2022 and August 5, 2023."}],"balance_after":146269,"source":{"system":"sec-edgar","filing":"0000914190-21-000014","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000014/edgar.xml","form_type":"4"}},{"id":2952561,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-12-09T21:28:05.000Z","date":"2020-12-07","kind":"sale","acquired":false,"shares":5000,"price":308,"value":1540000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes (i) 3,759 shares of restricted stock for which the risk of forfeiture will lapse on August 8, 2021; (ii) 7,527 shares of restricted stock for which the risk of forfeiture will lapse with respect to 3,764 shares on August 7, 2021 and as to 3,763 shares on August 7, 2022; and (iii) 8,586 shares of restricted stock for which the risk of forfeiture will lapse as to 2,862 shares on each of August 5, 2021, August 5, 2022 and August 5, 2023."}],"balance_after":166269,"source":{"system":"sec-edgar","filing":"0000914190-20-000444","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419020000444/edgar.xml","form_type":"4"}},{"id":2987366,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-11-10T23:04:48.000Z","date":"2020-11-06","kind":"exercise","acquired":false,"shares":25157,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":86.25,"expiration_date":"2021-04-01","underlying":"Common Stock","underlying_shares":25157},"source":{"system":"sec-edgar","filing":"0000914190-20-000399","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419020000399/edgar.xml","form_type":"4"}},{"id":2987365,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-11-10T23:04:48.000Z","date":"2020-11-06","kind":"tax_withholding","acquired":false,"shares":15375,"price":302.47,"value":4650476.25,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes (i) 3,759 shares of restricted stock for which the risk of forfeiture will lapse on August 8, 2021; (ii) 7,527 shares of restricted stock for which the risk of forfeiture will lapse with respect to 3,764 shares on August 7, 2021 and as to 3,763 shares on August 7, 2022; and (iii) 8,586 shares of restricted stock for which the risk of forfeiture will lapse as to 2,862 shares on each of August 5, 2021, August 5, 2022 and August 5, 2023."}],"balance_after":171269,"source":{"system":"sec-edgar","filing":"0000914190-20-000399","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419020000399/edgar.xml","form_type":"4"}},{"id":2987364,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-11-10T23:04:48.000Z","date":"2020-11-06","kind":"exercise","acquired":true,"shares":25157,"price":86.25,"value":2169791.25,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes (i) 3,759 shares of restricted stock for which the risk of forfeiture will lapse on August 8, 2021; (ii) 7,527 shares of restricted stock for which the risk of forfeiture will lapse with respect to 3,764 shares on August 7, 2021 and as to 3,763 shares on August 7, 2022; and (iii) 8,586 shares of restricted stock for which the risk of forfeiture will lapse as to 2,862 shares on each of August 5, 2021, August 5, 2022 and August 5, 2023."}],"balance_after":186644,"source":{"system":"sec-edgar","filing":"0000914190-20-000399","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419020000399/edgar.xml","form_type":"4"}},{"id":3062527,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2020-08-11T22:20:46.000Z","date":"2020-08-09","kind":"exercise","acquired":false,"shares":21291,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On 8/9/2020, the Board of Directors certified vesting of 21,291 performance RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On 8/9/2020, the Board of Directors certified vesting of 21,291 performance RSUs."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":21291},"source":{"system":"sec-edgar","filing":"0000914190-20-000289","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419020000289/edgar.xml","form_type":"4"}},{"id":3062526,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-08-11T22:20:46.000Z","date":"2020-08-09","kind":"tax_withholding","acquired":false,"shares":12287,"price":265.76,"value":3265393.12,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes (i) 3,759 shares of restricted stock for which the risk of forfeiture will lapse on August 8, 2021; (ii) 7,527 shares of restricted stock for which the risk of forfeiture will lapse with respect to 3,764 shares on August 7, 2021 and as to 3,763 shares on August 7, 2022; and (iii) 8,586 shares of restricted stock for which the risk of forfeiture will lapse as to 2,862 shares on each of August 5, 2021, August 5, 2022 and August 5, 2023."}],"balance_after":161487,"source":{"system":"sec-edgar","filing":"0000914190-20-000289","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419020000289/edgar.xml","form_type":"4"}},{"id":3062525,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-08-11T22:20:46.000Z","date":"2020-08-09","kind":"exercise","acquired":true,"shares":21291,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes (i) 3,759 shares of restricted stock for which the risk of forfeiture will lapse on August 8, 2021; (ii) 7,527 shares of restricted stock for which the risk of forfeiture will lapse with respect to 3,764 shares on August 7, 2021 and as to 3,763 shares on August 7, 2022; and (iii) 8,586 shares of restricted stock for which the risk of forfeiture will lapse as to 2,862 shares on each of August 5, 2021, August 5, 2022 and August 5, 2023."}],"balance_after":173774,"source":{"system":"sec-edgar","filing":"0000914190-20-000289","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419020000289/edgar.xml","form_type":"4"}},{"id":3065291,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-08-07T23:07:03.000Z","date":"2020-08-05","kind":"grant","acquired":true,"shares":16650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F14","text":"Options to purchase 5,550 shares vest on each of 8/5/21, 8/5/22 and 8/5/23."}],"balance_after":16650,"derivative":{"exercise_price":267.87,"expiration_date":"2027-08-05","underlying":"Common Stock","underlying_shares":16650},"source":{"system":"sec-edgar","filing":"0000914190-20-000253","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419020000253/edgar.xml","form_type":"4"}},{"id":3065290,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-08-07T23:07:03.000Z","date":"2020-08-05","kind":"grant","acquired":true,"shares":16650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021"}],"balance_after":16650,"derivative":{"exercise_price":267.87,"expiration_date":"2027-08-05","underlying":"Common Stock","underlying_shares":16650},"source":{"system":"sec-edgar","filing":"0000914190-20-000253","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419020000253/edgar.xml","form_type":"4"}},{"id":3065289,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-08-07T23:07:03.000Z","date":"2020-08-05","kind":"grant","acquired":true,"shares":38295,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"Options to purchase 9,574 shares vest on each of 8/5/21, 8/5/22 and 8/5/23 and options to purchase 9,573 shares vest on 8/5/24."}],"balance_after":38295,"derivative":{"exercise_price":267.87,"expiration_date":"2027-08-05","underlying":"Common Stock","underlying_shares":38295},"source":{"system":"sec-edgar","filing":"0000914190-20-000253","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419020000253/edgar.xml","form_type":"4"}},{"id":3065288,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-08-07T23:07:03.000Z","date":"2020-08-05","kind":"grant","acquired":true,"shares":57442,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator)."}],"balance_after":57442,"derivative":{"exercise_price":267.87,"expiration_date":"2027-08-05","underlying":"Common Stock","underlying_shares":57442},"source":{"system":"sec-edgar","filing":"0000914190-20-000253","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419020000253/edgar.xml","form_type":"4"}},{"id":3065287,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2020-08-07T23:07:03.000Z","date":"2020-08-05","kind":"grant","acquired":true,"shares":12879,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F11","text":"Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator)."}],"balance_after":12879,"derivative":{"underlying":"Common Stock","underlying_shares":12879},"source":{"system":"sec-edgar","filing":"0000914190-20-000253","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419020000253/edgar.xml","form_type":"4"}},{"id":3065286,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-08-07T23:07:03.000Z","date":"2020-08-05","kind":"grant","acquired":true,"shares":8586,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes (i) 4,732 shares of restricted stock for which the risk of forfeiture will lapse on August 9, 2020; (ii) 7,519 shares of restricted stock for which the risk of forfeiture will lapse as to 3,760 shares on August 8, 2020 and as to 3,759 shares on August 8, 2021; (iii) 7,527 shares of restricted stock for which the risk of forfeiture will lapse with respect to 3,764 shares on August 7, 2021 and as to 3,763 shares on August 7, 2022; and (iv) 8,586 shares of restricted stock for which the risk of forfeiture will lapse as to 2,862 shares on each of August 5, 2021, August 5, 2022 and August 5, 2023."}],"balance_after":152483,"source":{"system":"sec-edgar","filing":"0000914190-20-000253","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419020000253/edgar.xml","form_type":"4"}},{"id":3132841,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-05-28T21:41:35.000Z","date":"2020-05-26","kind":"exercise","acquired":false,"shares":21159,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully exercisable."}],"balance_after":25157,"derivative":{"exercise_price":86.25,"expiration_date":"2021-04-01","underlying":"Common Stock","underlying_shares":21159},"source":{"system":"sec-edgar","filing":"0000914190-20-000186","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419020000186/edgar.xml","form_type":"4"}},{"id":3132840,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-05-28T21:41:35.000Z","date":"2020-05-26","kind":"tax_withholding","acquired":false,"shares":13018,"price":266.4,"value":3467995.2,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes (i) 4,732 shares of restricted stock for which the risk of forfeiture will lapse on August 9, 2020; (ii) 7,519 shares of restricted stock for which the risk of forfeiture will lapse as to 3,760 shares on August 8, 2020 and as to 3,759 shares on August 8, 2021; and (iii) 11,291 shares of restricted stock for which the risk of forfeiture will lapse with respect to 3,764 shares on each of August 7, 2020 and August 7, 2021 and as to 3,763 shares on August 7, 2022."}],"balance_after":138130,"source":{"system":"sec-edgar","filing":"0000914190-20-000186","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419020000186/edgar.xml","form_type":"4"}},{"id":3132839,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-05-28T21:41:35.000Z","date":"2020-05-26","kind":"exercise","acquired":true,"shares":21159,"price":86.25,"value":1824963.75,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes (i) 4,732 shares of restricted stock for which the risk of forfeiture will lapse on August 9, 2020; (ii) 7,519 shares of restricted stock for which the risk of forfeiture will lapse as to 3,760 shares on August 8, 2020 and as to 3,759 shares on August 8, 2021; and (iii) 11,291 shares of restricted stock for which the risk of forfeiture will lapse with respect to 3,764 shares on each of August 7, 2020 and August 7, 2021 and as to 3,763 shares on August 7, 2022."}],"balance_after":151148,"source":{"system":"sec-edgar","filing":"0000914190-20-000186","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419020000186/edgar.xml","form_type":"4"}},{"id":3135843,"issuer":{"id":4845,"kind":"organization","name":"Gentherm Inc","symbol":"THRM"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-26T20:31:52.000Z","date":"2020-05-21","kind":"grant","acquired":true,"shares":4467,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares represent Restricted Common Stock issued under the 2013 Equity Incentive Plan that has been granted to the Reporting Person as compensation for serving on the Gentherm Board of Directors."}],"balance_after":8639,"source":{"system":"sec-edgar","filing":"0001209191-20-032018","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/903129/000120919120032018/doc4.xml","form_type":"4"}},{"id":3315692,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-01-08T21:34:47.000Z","date":"2020-01-06","kind":"exercise","acquired":false,"shares":10276,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully exercisable."}],"balance_after":100,"derivative":{"exercise_price":67.46,"expiration_date":"2020-04-01","underlying":"Common Stock","underlying_shares":10276},"source":{"system":"sec-edgar","filing":"0000914190-20-000018","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419020000018/edgar.xml","form_type":"4"}},{"id":3315691,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-01-08T21:34:47.000Z","date":"2020-01-06","kind":"sale","acquired":false,"shares":10276,"price":217.28,"value":2232769.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2019 and amended on June 7, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $217.00 to $217.83, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes (i) 4,732 shares of restricted stock for which the risk of forfeiture will lapse on August 9, 2020; (ii) 7,519 shares of restricted stock for which the risk of forfeiture will lapse as to 3,760 shares on August 8, 2020 and as to 3,759 shares on August 8, 2021; and (iii) 11,291 shares of restricted stock for which the risk of forfeiture will lapse with respect to 3,764 shares on each of August 7, 2020 and August 7, 2021 and as to 3,763 shares on August 7, 2022."}],"balance_after":129989,"source":{"system":"sec-edgar","filing":"0000914190-20-000018","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419020000018/edgar.xml","form_type":"4"}},{"id":3315690,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-01-08T21:34:47.000Z","date":"2020-01-06","kind":"exercise","acquired":true,"shares":10276,"price":67.46,"value":693218.96,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes (i) 4,732 shares of restricted stock for which the risk of forfeiture will lapse on August 9, 2020; (ii) 7,519 shares of restricted stock for which the risk of forfeiture will lapse as to 3,760 shares on August 8, 2020 and as to 3,759 shares on August 8, 2021; and (iii) 11,291 shares of restricted stock for which the risk of forfeiture will lapse with respect to 3,764 shares on each of August 7, 2020 and August 7, 2021 and as to 3,763 shares on August 7, 2022."}],"balance_after":140265,"source":{"system":"sec-edgar","filing":"0000914190-20-000018","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419020000018/edgar.xml","form_type":"4"}},{"id":3320114,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-01-06T21:39:43.000Z","date":"2020-01-03","kind":"exercise","acquired":false,"shares":7999,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Fully exercisable."}],"balance_after":10376,"derivative":{"exercise_price":67.46,"expiration_date":"2020-04-01","underlying":"Common Stock","underlying_shares":7999},"source":{"system":"sec-edgar","filing":"0000914190-20-000014","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419020000014/edgar.xml","form_type":"4"}},{"id":3320113,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":39055,"kind":"person","name":"Kummeth Charles R.","position":1,"cik":"0001534980","reported_name":"Kummeth Charles R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-01-06T21:39:43.000Z","date":"2020-01-02","kind":"exercise","acquired":false,"shares":19843,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Fully exercisable."}],"balance_after":18375,"derivative":{"exercise_price":67.46,"expiration_date":"2020-04-01","underlying":"Common Stock","underlying_shares":19843},"source":{"system":"sec-edgar","filing":"0000914190-20-000014","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419020000014/edgar.xml","form_type":"4"}}],"next_cursor":"2020-01-06T21:39:43.000000Z,3320113"}